WCBG's New Manufacturing and R&D Facility Launches at Laverton North GLC Base in Melbourne
Melbourne, August 2023 - WCBG is thrilled to announce the official commencement of its state-of-the-art manufacturing and research facility at the Laverton North GLC base in Melbourne. This strategic move reflects WCBG's commitment to innovation and collaboration within the biotechnology sector.
The Laverton North GLC base represents a milestone achievement in WCBG's partnership with the Australian Marine Bioproducts Cooperative Research Centre (MB-CRC) and the Australian Research Council (ARC) Training Centre for Green Chemistry in Manufacturing project. Backed by substantial support from the Australian government, this facility is poised to become a cornerstone of WCBG's research and production efforts within Australia.
The base will focus on a range of cutting-edge research initiatives, including algae extract studies, gene editing research, and the exploration of 3D bioprinting technology. This collaborative hub will not only drive WCBG's internal research but also foster a collaborative ecosystem that advances scientific progress in these fields.
Furthermore, the facility will serve as a pivotal production site for cosmetic and health products. Leveraging the latest advancements in biotechnology, WCBG aims to translate its research findings into tangible products that benefit consumers worldwide. By establishing a strong manufacturing presence at the Laverton North GLC base, WCBG aims to meet the growing demand for innovative, high-quality cosmetic and health solutions.
The inauguration of this facility marks a significant step forward in WCBG's mission to contribute to the advancement of biotechnology, green chemistry, and sustainable manufacturing practices. With its focus on collaboration and state-of-the-art research, WCBG's Laverton North GLC base is set to redefine the landscape of bioproduct development and production in Australia and beyond.
Melbourne, August 2023 - WCBG is thrilled to announce the official commencement of its state-of-the-art manufacturing and research facility at the Laverton North GLC base in Melbourne. This strategic move reflects WCBG's commitment to innovation and collaboration within the biotechnology sector.
The Laverton North GLC base represents a milestone achievement in WCBG's partnership with the Australian Marine Bioproducts Cooperative Research Centre (MB-CRC) and the Australian Research Council (ARC) Training Centre for Green Chemistry in Manufacturing project. Backed by substantial support from the Australian government, this facility is poised to become a cornerstone of WCBG's research and production efforts within Australia.
The base will focus on a range of cutting-edge research initiatives, including algae extract studies, gene editing research, and the exploration of 3D bioprinting technology. This collaborative hub will not only drive WCBG's internal research but also foster a collaborative ecosystem that advances scientific progress in these fields.
Furthermore, the facility will serve as a pivotal production site for cosmetic and health products. Leveraging the latest advancements in biotechnology, WCBG aims to translate its research findings into tangible products that benefit consumers worldwide. By establishing a strong manufacturing presence at the Laverton North GLC base, WCBG aims to meet the growing demand for innovative, high-quality cosmetic and health solutions.
The inauguration of this facility marks a significant step forward in WCBG's mission to contribute to the advancement of biotechnology, green chemistry, and sustainable manufacturing practices. With its focus on collaboration and state-of-the-art research, WCBG's Laverton North GLC base is set to redefine the landscape of bioproduct development and production in Australia and beyond.
